Ariad Pharmaceuticals Gets Price Target Boost; Target Corp. CEO Gregg Steinhafel Resigns

Follow this company

Companies Mentioned

05/06/2014 [ACCESSWIRE]

Target Corp. (NYSE: TGT) - For an in-depth report on Target Corp. follow:

Shares of Target Corp. closed down 3.45% on about 16.2 million shares traded. Target CEO Gregg Steinhafel has decided to step down. This comes less than 5 months after hackers gained access to as many as 70 million accounts during the company’s massive data breach.

Plug Power Inc. (NASDAQ: PLUG) - For an in-depth report on Plug Power Inc. follow:

Shares of Plug Power closed down 9.78% on Monday with about 27.5 million shares traded. The stock was one of the biggest decliners on the NASDAQ. The company tripped a Nasdaq short-sale circuit breaker that imposes restrictions on prices at which securities may be sold short. About 30% of the company’s shares are sold short, according to FactSet.

Zoned Properties Inc. (OTC: ZDPY) - For an in-depth report on Zoned Properties Inc. follow:

Shares of Zoned Properties Inc. closed down 40.54% on Monday with about 700,000 shares traded. The stock was one of the biggest decliners in the OTC marketplace. On May 2nd, the company announced plans to do a 1:120 reverse stock split. Paperwork has already been filed with FINRA and the company expects it to go into effect within ten days.

Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) - For an in-depth report on Ariad Pharmaceuticals Inc. follow:

Shares of ARIA closed up 5.53% on about 14 million shares traded. The stock was one of the biggest gainers on the NASDAQ and one of the most active stocks on Monday. Shares were upgraded to "buy" from "hold" at Jefferies Group and got a price target bump from $8.00 to $14.00.


Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.


Leave a comment...

Your Name